Abstract
Frontal circuits play a critical role in motor, cognitive, and affective processing – and their dysfunction may result in a variety of brain disorders. However, exactly which frontal domains mediate which (dys)function remains largely elusive. Here, we study 534 deep brain stimulation electrodes implanted to treat four different brain disorders. By analyzing which connections were modulated for optimal therapeutic response across these disorders, we segregate the frontal cortex into circuits that became dysfunctional in each of them. Dysfunctional circuits were topographically arranged from occipital to rostral, ranging from interconnections with sensorimotor cortices in dystonia, with the primary motor cortex in Tourette’s syndrome, the supplementary motor area in Parkinson’s disease, to ventromedial prefrontal and anterior cingulate cortices in obsessive-compulsive disorder. Our findings highlight the integration of deep brain stimulation with brain connectomics as a powerful tool to explore couplings between brain structure and functional impairment in the human brain.
Competing Interest Statement
J.L.O. reports research grant support from Medtronic and Boston Scientific and is a consultant for Abbott, outside of the submitted work. M.M.R. reports grant support and honoraria for speaking from Medtronic and Boston Scientific, outside of the submitted work. J.V. reports grants and personal fees from Medtronic Inc., grants, and personal fees from Boston Scientific, personal fees from Abbott, outside of the submitted work. H.B. is consultant of Alpha-Omega, outside of the submitted work. S.C. is consultant for Medtronic and Boston Scientific, outside of the submitted work. A.H. is a consultant for FxNeuromodulation and Abbott, and reports lecture fees from Boston Scientific, outside of the submitted work. B.H., I.A.S., N.R., S.O., K.B., C.N., P.R., P.Z., M.P., H.A., M.V., C.Z., B.S., P.N., F.-C.Y., J.C.B., T.A.D., V.V.-V., E.J.L.A., P.R.F., C.F., A.A.K., P.N., D.D.D., R.M.R., M.R.D., A.M., L.M.R., H.T., L.Z., E.M.J., P.A.S., and N.L. report no competing interests.
Funding Statement
B.H., I.A.S. and P.Z. were supported via a scholarship from the Einstein Center for Neurosciences Berlin. The work conducted at the University of California San Francisco (J.L.O. and P.A.S.) received support by a grant from the Benign Essential Blepharospasm Research Foundation and philanthropic support from Larry and Kana Miao. M.V. was supported by institutional funds from Scuola Superiore Sant'Anna. Further, this work received support by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): 424778381 - TRR 295 to M.M.R., J.V, A.A.K., H.B., A.H. and N.L., 347325977 to A.A.K., FI 2309/1-1 and FI 2309/2-1 to C.F. L.M.R. was supported by the Italian Ministry of Health grant GR-2009-1594645. AH was moreover supported by Deutsches Zentrum fuer Luft- und Raumfahrt (DynaSti grant within the EU Joint Programme Neurodegenerative Disease Research, JPND), the National Institutes of Health (R01 13478451, 1R01NS127892-01 & 2R01 MH113929) as well as the New Venture Fund (FFOR Seed Grant).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All analyses performed for the purpose of the present manuscript were approved by the institutional review board of Charite - Universitaetsmedizin Berlin (master vote EA2/186/18) and treatment of data complied with all relevant ethical regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Our revision includes a multitude of novel analyses that build on data from additional 70 patients from five centers. In this new iteration of the manuscript, we integrated eight revised figures, ten newly included (supplementary) figures, and five newly created tables. Critically, we were able to validate the Parkinson's disease and obsessive-compulsive disorder circuit models using i) two newly added additional cohorts, and ii) three prospective patient cases that were reprogrammed and/or surgically targeted according to the circuit models. We replicate dysfunction mappings using disease-specific connectomes, i.e., now confirm general results using a total number of six different connectome datasets. In a set of control analyses, we demonstrate that the circuits are not merely an effect of differences in surgical targeting across disorders.
Data availability
Detailed patient-wise demographic and clinical information is available in the supplementary materials in anonymized form. Patient imaging data cannot be publicly shared as this would compromise patient privacy according to current data protection regulations. It is, however, available from the principal investigators of the collecting sites upon reasonable request within the framework of a data sharing agreement. The sweet streamline atlas and sweet spots of all four disorders are openly available within Lead-DBS software, v3.0 (www.lead-dbs.org). While a processed version of the HCP 985 Connectome 27 can be requested from the corresponding authors, source data are freely accessible via the repository of the HCP (https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-release). Further, the DBS Tractography Atlas, v2 can be openly downloaded via the Lead-DBS knowledge base (https://www.lead-dbs.org/helpsupport/knowledge-base/atlasesresources/normative-connectomes/). The HCP-1,065 diffusion source data 95 used to inform this atlas can be openly accessed via DSI-Studio (https://sites.google.com/a/labsolver.org/brain/diffusion-mri-data/hcp-dmri-data). The following normative resources have been made openly available by the original authors: the MGH 760 µm Connectome 25 (https://datadryad.org/stash/dataset/doi:10.5061/dryad.nzs7h44q2) and the Basal Ganglia Pathway Atlas 38 (https://osf.io/mhd4z/). The PD-matched PPMI-85 connectome can be openly and publicly derived via the Lead-DBS knowledge base (https://www.lead-dbs.org/helpsupport/knowledge-base/atlasesresources/normative-connectomes/). Source data used for calculation of this connectome can be freely accessed via the homepage of the PPMI (www.ppmi-info.org). The OCD-matched connectome can be shared by the corresponding authors upon reasonable request. Source data of OCD patients employed to calculate this connectome cannot be publicly shared due to patient privacy restrictions.
Abbreviations
- ANTs
- Advanced Normalization Tools
- BFMDRS
- Burke-Fahn-Marsden Dystonia Rating Scale
- CIT168 atlas
- California Institute of Technology reinforcement learning atlas
- CV
- Cross-validation
- CT
- computed tomography
- DBS
- deep brain stimulation
- DISTAL
- DBS intrinsic template atlas
- dMRI
- diffusion-weighted magnetic resonance imaging
- DYT
- dystonia
- E-field
- electric field magnitude
- FEM
- finite element method
- fMRI
- functional magnetic resonance imaging
- GPe
- external pallidum (globus pallidus, external segment)
- GPi
- internal pallidum (globus pallidus, internal segment)
- HCP
- Human Connectome Project
- JHU atlas
- Johns Hopkins University atlas
- MGH
- Massachusetts General Hospital
- MNI space
- ICBM 2009b Non-linear Asymmetric template space
- M1
- primary motor cortex
- MRI
- magnetic resonance imaging
- OCD
- obsessive-compulsive disorder
- PD
- Parkinson’s disease
- PaCER algorithm
- Precise and Convenient Electrode Reconstruction for Deep Brain Stimulation algorithm
- SMA
- supplementary motor area
- SPM12 software
- Statistical Parametric Mapping software
- STN
- subthalamic nucleus
- SyN approach
- Symmetric Normalization approach
- TRAC/CORE algorithm
- trajectory search/contact reconstructions algorithm
- TS
- Tourette’s syndrome
- UPDRS-III
- Unified Parkinson’s Disease Rating Scale – Part III
- VC/VS
- ventral capsule/ventral striatum
- Y-BOCS
- Yale-Brown Obsessive-Compulsive Scale
- YGTSS
- Yale Global Tic Severity Scale
